课题基金 / 基金详情

Development of SFS Fractionators

Development of SFS Fractionators
SFS分馏塔的开发
批准号:
8712743
负责人:
TREVOR P. CASTOR
金额:
$22.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2014-11-30

项目摘要

项目成果

TREVOR P. CASTOR的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在特定活动的敏感筛查中,对复杂的分析物混合物的筛选并不总是成功的。通常,干扰化合物掩盖了特定的活动,或与所有屏幕相互作用的无处不在的化合物给出了假阳性。这个问题可以通过提纯分析物来解决。这种方法不仅成本高昂,而且还会导致偏向于分离高浓度的分析物。传统的有机溶剂并不总是生物质提取的理想溶剂。这些溶剂很难从可能显示生物活性的化合物中去除,因此可以在检测中掩盖生物活性。为了加强药物和膳食补充剂的发现过程,我们开发了使用超临界流体溶剂对植物和微生物进行极性引导分级的方法并获得了专利(Castor等人,1998,2003)。该研究项目的总体目标是开发一种商业的、用户友好的SuperFluidsTM CXF分馏器,大学和制药公司的研究人员可以利用该分级器来促进药物发现和保健产品开发过程。第一阶段的主要目标是设计一个并行处理CXF分馏器,并构建和测试一个能够根据预定义的顺序递增极性协议处理样品的单单元CXF原型。该装置将有能力从陆地植物和海洋微生物中快速生产部分纯化的天然产品分子,例如,在大约1小时内生产6个不同的极性组分。在第一阶段,我们计划设计SuperFluidsTM CXF原型,构建原型的关键组件,并测试这些组件。在第二阶段,我们计划完成SuperFluidsTM分馏装置的硬件和软件设计,组装单一和并行处理的Alpha-Site装置,在Beta-Site测试这些装置,并根据需要重新设计和重建,以消除错误和增加用户友好性。在第三阶段,OEM公司将制造商业单位。在第三阶段,我们计划向大学以及营养食品、食品、制药和生物技术公司的研究人员和产品开发人员出售SFS分馏装置,其中将包括使用SFS-CXF技术和设备的许可证。
英文摘要
DESCRIPTION (provided by applicant): The screening of a complex mixture of analytes is not always successful in sensitive screens for specific activities. Often, specific activities are masked by interfering compounds or false positives are given by ubiquitous compounds that interact with all screens. This problem can be resolved by purification of the analytes. Such an approach is not only cost-prohibitive but will also result in biasing the isolation of analytes tha occur in higher concentrations. Conventional organic solvents are not always ideal for biomass extractions. These solvents can be difficult to remove from the compounds potentially exhibiting bioactivity and, thus can mask bioactivity in an assay. In order to enhance the drug and dietary supplement discovery process, we have developed and patented processes for the polarity-guided fractionation of plants and microbes (Castor et al., 1998, 2003) using supercritical fluid solvents. The overall goal of this research project is to develop a commercial, user-friendly SuperFluidsTM CXF fractionator that can be utilized by researchers at universities and pharmaceutical companies to facilitate the drug discovery and nutraceutical product development process. The primary Phase I object is to design a parallel processing CXF fractionator, and to construct and test a single unit CXF prototype that can process samples in accordance to a pre-defined sequentially increasing-polarity protocol. The unit will have the capability to rapidly produce partially purified natural product molecules from terrestrial plants and marine microorganisms, for example, 6 varying polarity fractions in about 1 hour. In Phase I, we plan to design SuperFluidsTM CXF prototypes, construct key components of the prototypes, and test these components. In Phase II, we plan to complete the hardware and software design of the SuperFluidsTM fractionation unit, assemble single and parallel processing Alpha-site units, test the units at a Beta-site, and redesign and reconstruct as necessary to eliminate bugs and increase user-friendliness. In Phase III, OEM companies will manufacture commercial units. In Phase III, we plan to sell SFS fractionation units, which will include license to utilize the SFS-CXF technologies and equipment, to researchers and product developers at universities as well as nutraceutical, food, pharmaceutical and biotechnology companies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Double-Encapsulated mRNA Vaccine for COVID-19
  • 批准号:
    10611763
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2023
  • 负责人:
    TREVOR P. CASTOR
  • 依托单位:
Combination Therapeutic for Chronic Opioid Use Disorder Relapse
  • 批准号:
    10706844
  • 项目类别:
  • 资助金额:
    $33.57万
  • 财政年份:
    2023
  • 负责人:
    TREVOR P. CASTOR
  • 依托单位:
Development of cGMP Manufacturing Process for CBD
  • 批准号:
    8966448
  • 项目类别:
  • 资助金额:
    $74.21万
  • 财政年份:
    2015
  • 负责人:
    TREVOR P. CASTOR
  • 依托单位:
Development of cGMP Manufacturing Process for CBD
  • 批准号:
    8834719
  • 项目类别:
  • 资助金额:
    $22.48万
  • 财政年份:
    2014
  • 负责人:
    TREVOR P. CASTOR
  • 依托单位:
海外基金